Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.

E-ISSN： 1876-1038|8|2|128-135

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.8, Iss.2, 2013-06, pp. : 128-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A critical ethnography of communication processes involving the management of oral chemotherapeutic agents by patients with a primary diagnosis of colorectal cancer: study protocol

JOURNAL OF ADVANCED NURSING, Vol. 71, Iss. 4, 2015-04 ,pp. : 922-932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Strategic Options on Behalf of Patients with Metastatic Colorectal Cancer: Mass Tumor Murder versus Serial Tumor Killing

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 291-292

Karger

Access to resources Recommend Favorite

Thymidylate Synthase: A Target for Combination Therapy and Determinant of Chemotherapeutic Response in Colorectal Cancer

Oncology, Vol. 57, Iss. 3, 1999-10 ,pp. : 179-194

Karger

Access to resources Recommend Favorite

Folate in colorectal cancer, prostate cancer and cardiovascular disease

By Van Guelpen B.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 5, 2007-01 ,pp. : 459-473

Informa Healthcare

Access to resources Recommend Favorite

Treatment Options for Advanced Colorectal Cancer Continue to Improve

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 372-373

Karger

Access to resources Recommend Favorite